Skip to main content
Uni-Bio Science Group Limited logo

Uni-Bio Science Group Limited — Investor Relations & Filings

Ticker · 690 HKEX Manufacturing
Open in API
Filings indexed 1,066 across all filing types
Latest filing 2020-05-08 Share Issue/Capital Cha…
Country HK Hong Kong
Listing HKEX 690

About Uni-Bio Science Group Limited

http://www.uni-bioscience.com

Uni-Bio Science Group Limited is an innovative biopharmaceutical enterprise specializing in the R&D, manufacturing, and sales of biological and chemical pharmaceutical products. The company's core strategy centers on regenerative medicine, focusing on therapeutic areas such as endocrinology, dermatology, and ophthalmology. Key research pipelines address bone and muscle regeneration (including osteoporosis), skin and tissue repair (burns, chronic wounds, and medical aesthetics), and ocular regeneration (corneal damage and macular degeneration). Unique technological platforms include the ECO-KSFA® micro-protein manufacturing system for high-stability biologics and smart hydrogel technology for advanced tissue engineering and targeted delivery solutions.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks for Uni-Bio Science Group Limited. It includes detailed information on shares issued, shares repurchased, dates, prices, and confirmations related to compliance with listing rules. The content focuses on reporting share capital changes and share repurchase activities, which aligns with announcements regarding share issues or capital changes. The document is not a full financial report, earnings release, or management discussion, but a regulatory disclosure about share capital changes and buybacks. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length (8422 characters) supports it being a substantive disclosure rather than a brief announcement or certification.
2020-05-08 English
Next Day Disclosure Return
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks for Uni-Bio Science Group Limited. It includes detailed information on shares issued, shares repurchased, dates, prices, and confirmations regarding compliance with listing rules. The content focuses on reporting share capital changes and repurchase activities, which aligns with announcements about share issues or capital changes. There is no indication that this is a full financial report, audit, or earnings release. The document is not a brief announcement of a report publication but a substantive disclosure of share capital changes. Therefore, the most appropriate classification is 'Share Issue/Capital Change' (SHA). The document length (8344 characters) supports it being a full disclosure rather than a brief announcement.
2020-05-07 English
Next Day Disclosure Return
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks for Uni-Bio Science Group Limited. It includes detailed information on share repurchases, issued shares, and confirmations related to compliance with listing rules. The content focuses on disclosures about share capital changes and repurchases, which aligns with announcements regarding share issues or capital changes. The document is not a full financial report, earnings release, or management discussion, but a regulatory disclosure about share capital changes and buybacks. Therefore, the most appropriate classification is 'Share Issue/Capital Change' (SHA). The document length and detail support this classification with high confidence.
2020-05-06 English
Next Day Disclosure Return
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Uni-Bio Science Group Limited. It includes detailed information on share repurchases, issued shares, prices, and confirmations related to compliance with listing rules. The content focuses on reporting share capital changes and share repurchase activities, which aligns with announcements regarding share issues or capital changes. There is no indication that this is a full financial report, audit, or earnings release. The document is not a brief announcement of a report publication but a detailed disclosure of share capital changes. Therefore, the most appropriate classification is 'Share Issue/Capital Change' (SHA).
2020-05-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2020
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' and is addressed to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, share options, warrants, convertibles, and other share-related capital changes for the month ended 30 April 2020. The content focuses on share capital changes, share options, and related securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting monthly equity movements rather than a financial report or announcement of voting results. The document is comprehensive and contains substantive data on share capital movements, not just a brief announcement or certification. Therefore, it fits best under the category of Share Issue/Capital Change (SHA).
2020-05-04 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued share capital and share buybacks for Uni-Bio Science Group Limited. It includes detailed information on share issues, repurchases, and confirmations related to compliance with listing rules on the Hong Kong Stock Exchange. The content focuses on disclosures about share capital changes and repurchase activities rather than financial results, management changes, or other report types. This matches the description of a Transaction in Own Shares (POS) filing, which reports company buybacks or sales of its own shares. The document length (8139 characters) and detailed transactional data support this classification rather than a brief announcement or a regulatory filing fallback.
2020-04-28 English

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.